Drug
Bisoprolol Fumarate And Hydrochlorothiazide
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Red Blood Cell Sedimentation Rate Increased | 14 | 43.2 | 44.1 | signal |
| 2 | Hypercalcaemia | 14 | 38.8 | 39.7 | signal |
| 3 | Basal Cell Carcinoma | 15 | 32.8 | 33.6 | signal |
| 4 | Ulcer | 15 | 32.2 | 33.0 | signal |
| 5 | Drug Eruption | 15 | 29.1 | 29.8 | signal |
| 6 | Pulmonary Fibrosis | 15 | 26.8 | 27.5 | signal |
| 7 | Synovitis | 13 | 24.6 | 25.1 | signal |
| 8 | Prescribed Underdose | 13 | 22.3 | 22.7 | signal |
| 9 | Skin Ulcer | 16 | 21.2 | 21.7 | signal |
| 10 | Full Blood Count Abnormal | 6 | 19.4 | 19.6 | signal |
| 11 | Hepatitis | 14 | 18.7 | 19.1 | signal |
| 12 | Obstructive Airways Disorder | 6 | 18.4 | 18.5 | signal |
| 13 | Lymphopenia | 7 | 17.0 | 17.2 | signal |
| 14 | Renal Failure Acute | 20 | 15.9 | 16.4 | signal |
| 15 | Deafness | 12 | 15.7 | 15.9 | signal |
| 16 | Sinus Disorder | 9 | 15.5 | 15.7 | signal |
| 17 | Rash Pruritic | 22 | 13.9 | 14.4 | signal |
| 18 | Contraindicated Product Administered | 12 | 13.6 | 13.8 | signal |
| 19 | Bedridden | 5 | 13.0 | 13.1 | signal |
| 20 | Respiratory Tract Congestion | 6 | 12.9 | 13.0 | signal |
| 21 | Therapeutic Product Effect Decreased | 14 | 10.8 | 11.0 | signal |
| 22 | Drug Reaction With Eosinophilia And Systemic Symptoms | 8 | 10.7 | 10.8 | signal |
| 23 | Inappropriate Antidiuretic Hormone Secretion | 3 | 10.1 | 10.1 | signal |
| 24 | Muscle Spasticity | 3 | 8.3 | 8.3 | signal |
| 25 | Completed Suicide | 11 | 4.5 | 4.5 | signal |
| 26 | Breast Cancer Female | 3 | 3.8 | 3.8 | no signal |